Anzeige
Mehr »
Login
Freitag, 22.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
InnoCan Pharma mit Newsbombe! Bereit für klinische Studien - Kursexplosion?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Apheresis Market Growth Forecast at 11.2% CAGR to 2020

PUNE, India, October 20, 2015 /PRNewswire/ --

Global apheresis market growth driven by rising incidences of blood disorders and chronic diseases is expected to reach USD 2.5 billion by 2020, growing at a CAGR of 11.2% during the forecast period of 2015 to 2020.

Complete report on apheresis market spread across 190 pages, profiling 12 companies and supported with 139 tables and 45 figures is now available at http://www.lifescienceindustryresearch.com/apheresis-market-therapeutic-donor-apheresisautomated-blood-component-collectionapplicationsplasmapheresisplateletpheresisrbcerythrocytapheresisleukapheresisphotopheresis-devices-dis.html .

In this report, the apheresis market is segmented by procedure, product, technology, application, and region. The apheresis market, by procedure, is mainly segmented into apheresis/automated blood collection and therapeutic apheresis. In 2014, the automated blood collection segment accounted for the largest share of approximately 77.2% of the apheresis market, and is expected to grow at a CAGR of 10.7% during the forecast period. Growth in this segment is mainly attributed to the increasing severity of blood shortage and growing concern regarding blood safety, and increasing incidences of blood disorders and chronic diseases.

On the basis of applications, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share-46.5%-of the global apheresis market in 2014. The large share of plasmapheresis is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.

In 2014, North America commanded the largest share of the global apheresis market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 47.8% of global apheresis market in 2014. The U.S. is a prime market due to the easy access to advanced apheresis devices through well-established distribution channels, increased collection of source plasma, and increasing incidences of blood disorders and chronic diseases. On the other hand, Asia-Pacific is the fastest-growing region in the global apheresis market, mainly driven by the increasing demand of blood components for the treatment of the large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investments by leading players and respective government agencies in the region.

Companies profiled in this apheresis market research cover Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.). Order a copy of Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020 at http://www.lifescienceindustryresearch.com/purchase?rname=2032 .

On a related note, another research titled Global Apheresis Equipment Market 2015-2019 forecasts global apheresis equipment market to grow at a CAGR of 10.72% over the period 2014-2019. To calculate the apheresis equipment market size, the report considers the revenue generated from the sales of various devices and disposables used in apheresis that are available in the market. The two major technologies discussed in the report are centrifugation and membrane filtration. Companies like Asahi Kasei Medical, Fenwal, Haemonetics, Macopharma, Terumo BCT, Cerus, Grifols, HemaCare, Hemagen Diagnostics, Immucor, Kawasumi Laboratories and Therakos are mentioned in this research available at http://www.lifescienceindustryresearch.com/global-apheresis-equipment-market-2015-2019.html .

Explore more reports on the medical devices industry at http://www.lifescienceindustryresearch.com/category/medical-devices .

About Us:

LifeScienceIndustryResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed/

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@lifescienceindustryresearch.com


Kostenloser Wertpapierhandel auf Smartbroker.de
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.